Lunai Bioworks Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Lunai Bioworks Inc. (LNAI) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$19.39 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2014-11-13
- Lunai Bioworks Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$19.39K.
- Lunai Bioworks Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was -$34.35K.
- Lunai Bioworks Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was -$13.95K.
- Lunai Bioworks Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2013-12-31 was -$56.39K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$19.39K 10-Q · filed 2014-11-13 | -$53.74K derived: sum of 2 quarters · filed 2014-11-13 | -$54.69K 10-Q · filed 2014-11-13 | -$124.08K derived: sum of 4 quarters · filed 2014-11-13 |
| 2014-06-30 | -$34.35K 10-Q · filed 2014-08-14 | -$35.30K 10-Q · filed 2014-08-14 | -$104.68K derived: sum of 3 quarters · filed 2014-08-14 | -$136.97K derived: sum of 4 quarters · filed 2014-11-13 |
| 2014-03-31 | -$13.95K 10-Q · filed 2014-05-14 | -$70.33K derived: sum of 2 quarters · filed 2014-08-14 | -$102.62K derived: sum of 3 quarters · filed 2014-11-13 | -$203.75K derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-12-31 | -$56.39K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-08-14 | -$88.67K derived: sum of 2 quarters · filed 2014-11-13 | -$189.81K derived: sum of 3 quarters · filed 2014-11-13 | -$408.41K 10-Q · filed 2014-08-14 |
| 2013-09-30 | -$32.28K 10-Q · filed 2014-11-13 | -$133.42K derived: sum of 2 quarters · filed 2014-11-13 | -$352.03K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$101.14K 10-Q · filed 2014-08-14 | -$319.74K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$218.61K 10-Q · filed 2014-05-14 | |||
| 2012-12-31 | -$503.62K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |